Kura Investors

Investor Home

Webcast ImageWebcast
Kura Oncology Inc at LEERINK Partners 6th Annual Global Healthcare Conference (Replay)
02/16/17 at 9:30 a.m. ET
Kura Oncology Inc at LEERINK Partners 6th Annual Global Healthcare Conference
Thursday, February 16, 2017 9:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Kura Oncology Inc at Cowen and Company 37th Annual Healthcare Conference (Live)
03/08/17 at 9:20 a.m. ET
Kura Oncology Inc at Cowen and Company 37th Annual Healthcare Conference
Wednesday, March 8, 2017 9:20 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
We are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Our development programs target cancers with high unmet need, including head and neck, lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.
Recent Newsmore >
02/09/17
Kura Oncology to Participate in Three Upcoming Investor Conferences
01/17/17
Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia
01/04/17
Kura Oncology Receives FDA Clearance to Proceed with Clinical Trial for ERK Inhibitor KO-947 and Nominates KO-539 as Development Candidate for Menin-MLL Inhibitor Program
Upcoming Events
DateTitleRemind
Me
Prior to
Event
03/08/17 9:20 a.m. ET
Kura Oncology Inc at Cowen and Company 37th Annual Healthcare Conference
days
03/21/17 1:35 p.m. ET
Kura Oncology Inc at Oppenheimer 27th Annual Healthcare Conference
days
Enter your e-mail address 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Kura Oncology Inc posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.